---
title: "Verdad Biotech Fund, L.P. SEC filings"
url: https://altstreet.investments/edgar/2139106
kind: edgar-entity
updated: 2026-07-31
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Verdad Biotech Fund, L.P.: SEC filings and what they report

Verdad Biotech Fund, L.P. is a longevity biotech-focused investment vehicle filed June 9, 2026, in pre-open status with no capital raised or investor count disclosed. The filing claims exemptions under Rule 506(b), 506(c), Rule 504, and Section 4(a)(5). Minimum investment was not disclosed on the filing.

| Field | Value |
| --- | --- |
| Entity | Verdad Biotech Fund, L.P. |
| CIK | 2139106 |
| Filing family | 506(b), 506(c), Rule 504, 4(a)(5) |
| Entity type | fund vehicle |
| Manager (as filed) | Verdad |
| Platform | Verdad Biotech Fund, L.P. (https://altstreet.investments/platforms/verdad-biotech-fund-lp) |
| Newest fact-bearing filing | June 9, 2026, accession 0002139106-26-000001 |
| Total sold (as reported) | $0 |
| Investors (as reported) | 9 |
| Vintage | 2026 |

## Filings (1 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| June 9, 2026 | D | Form D | https://www.sec.gov/Archives/edgar/data/2139106/000213910626000001/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/2139106
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002139106&owner=include&count=40
- Other issuers on Verdad Biotech Fund, L.P.: https://altstreet.investments/deals/platform/verdad-biotech-fund-lp
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/2139106
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.
